The Effect of Thiazolidinediones in Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis of Randomised Controlled Trials.

导出 LinkOut

翻译打印收藏纠错

作者： Mohammed A,Abdalla ^[1] ; Najeeb,Shah ^[2] ; Harshal,Deshmukh ^[3] ; Amirhossein,Sahebkar ^[3] ; Linda,Östlundh ^[4] ; Rami H,Al-Rifai ^[5] ; Stephen L,Atkin ^[6] ; Thozhukat,Sathyapalan ^[7]

作者单位： Allam Diabetes Centre, Academic Diabetes, Endocrinology and Metabolism, The University of Hull, Hull York Medical School (HYMS), Hull, UK. mohammed.ahmed@dasmaninstitute.org. ^[1] Dasman Diabetes Institute, Department of Translational Research, State of Kuwait, Kuwait City, Kuwait. mohammed.ahmed@dasmaninstitute.org. ^[2] Allam Diabetes Centre, Academic Diabetes, Endocrinology and Metabolism, The University of Hull, Hull York Medical School (HYMS), Hull, UK. ^[3] Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran. ^[4] Applied Biomedical Research Centre, Mashhad University of Medical Sciences, Mashhad, Iran. ^[5] School of Medicine, The University of Western Australia, Perth, Australia. ^[6] College of Medicine and Health Sciences, The National Medical Library, United Arab Emirates University, Al Ain, United Arab Emirates. ^[7] College of Medicine and Health Sciences, Institute of Public Health, United Arab Emirates University, Al Ain, United Arab Emirates. ^[8] School of Postgraduate Studies and Research, RCSI Medical University of Bahrain, Al Sayh, Kingdom of Bahrain. ^[9]

关键词 FBG FI Glitazones HOMA-B HOMA-IR Metformin PCOS Pharmacological therapy Pioglitazone Polycystic ovary syndrome Rosiglitazone